The biotechnology industry has been an engine of innovation for the U.S. healthcare system and, more generally, the U … American Industry Classification System (NAICS) as biotechnology firms to estimate several Fama-French three factor return … current study we find that biotechnology firms are exposed to greater financial risk than other industries and are also more …

North American Industry Classification System (NAICS) as biotechnology firms to estimate several Fama-French three factor …In the current study we find that biotechnology firms are exposed to greater financial risk than other industries and … capital over the 1982-2005 time period were 16.25 percent for biotechnology firms. Of course, these average estimates obscure …

This paper provides evidence on the mechanisms influencing the patent output of a sample of biotechnology firms from …. It focuses on biotechnology in the period 2002-2007 and is based on a unique data set drawn from various sources …&D investment. The overall picture emerging from our analysis of the determinants of patenting in biotechnology is that the …